S71 Evaluation of the Quality-of-Care Parameters in Patients With Inflammatory Bowel Disease in Brazilian Hospitals
Pancolitis
DOI:
10.14309/01.ajg.0000996028.23348.9c
Publication Date:
2023-12-14T05:25:24Z
AUTHORS (30)
ABSTRACT
Background: There are few data on the quality-of-care for inflammatory bowel disease (IBD) in public, private or mixed hospitals. Aim: To evaluated clinic and quality parameters their association with need ICU death Brazilian Methods: Multicentre study carried out 26 hospitals including 488 admissions of patients IBD were analyzed between June 2021 October 2022. Results: The median stay length was 6 days (0–121). age 38 years (16–87), 265 (54.6%) female; 339 (69.5%) had Crohn’s (CD) 149 (30.5%) ulcerative colitis (UC). In CD group, there structural damage 248 cases (73.2%). UC pancolitis form seen 97 (66%). Charlson Comorbidity Index (CCI) scored at least one point 182 records (37.3%). 307 (62.9%) urgent, 208 (42,6%) remained emergency room (ER) 2 (1-22). Disease activity accounted 58.6% admissions. 153 surgeries (37.5%), 35 (18.1%) postoperative complications. most prescribed drugs biologicals (52.8%) before admission corticosteroids during hospitalization period Red verified 45.3%. Admission to required 55 (11.3%). One hundred nine (22.3%) bacterial infections registered. 16 deaths (3.3%), main cause sepsis (37.5%). CCI 1 best predicted (AUROC 0.588; S 52.7%, E 64.7%) 0.782; 81.3%, 64.2%). intestinal resection (p=0.003; OD= 3.515; 95% IC, 1.516-8.156) infectious complications (p=0.006; 5.605; 2,508- 12,527) associated ICU. Admissions (p=0.013; OD=4,442; IC 1.314-14.358) (p=0.000; OD=10.823; 2.998-39.078) death. ER red lower (p= 0.000). Infection rates similar 0.323). Conclusions: accuracy predicting obtained. Infectious both outcomes. System deficiency more evident public proportion individuals who room. From days, greater agility solving problems found
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (0)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....